Interleukin-1 Blockade in Heart Failure With Preserved Ejection Fraction (HFpEF): a Randomized Placebo-controlled Double Blinded Study (D-HART2)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Anakinra (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms D-HART2
- 22 Aug 2017 Planned End Date changed from 1 Sep 2017 to 1 Nov 2017.
- 22 Aug 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Nov 2017.
- 22 Aug 2017 Status changed from recruiting to active, no longer recruiting.